Precision Optics Corporation, Inc. (POCI)
USD 5.01
(0.2%)
USD 5.01
(0.2%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 5.79 Million USD | -25.04% |
| 2023 | 7.73 Million USD | 56.94% |
| 2022 | 4.92 Million USD | 43.53% |
| 2021 | 3.43 Million USD | 2.11% |
| 2020 | 3.36 Million USD | 58.43% |
| 2019 | 2.12 Million USD | 43.23% |
| 2018 | 1.48 Million USD | 91.53% |
| 2017 | 773.72 Thousand USD | -17.87% |
| 2016 | 942.02 Thousand USD | 18.01% |
| 2015 | 798.27 Thousand USD | -0.32% |
| 2014 | 800.79 Thousand USD | 22.37% |
| 2013 | 654.42 Thousand USD | 17.41% |
| 2012 | 557.4 Thousand USD | -25.89% |
| 2011 | 752.11 Thousand USD | -42.02% |
| 2010 | 1.29 Million USD | -18.7% |
| 2009 | 1.59 Million USD | 101.47% |
| 2008 | 792 Thousand USD | 66.64% |
| 2007 | 475.27 Thousand USD | 11600.47% |
| 2006 | 4062.00 USD | 100.63% |
| 2005 | -647.76 Thousand USD | -8.33% |
| 2004 | -597.93 Thousand USD | -282.87% |
| 2003 | 326.97 Thousand USD | 124.24% |
| 2002 | -1.34 Million USD | -266.71% |
| 2001 | 809.14 Thousand USD | -46.95% |
| 2000 | 1.52 Million USD | 27.1% |
| 1999 | 1.2 Million USD | 33.33% |
| 1998 | 900 Thousand USD | -59.09% |
| 1997 | 2.2 Million USD | -21.43% |
| 1996 | 2.8 Million USD | 0.0% |
| 1995 | 2.8 Million USD | 47.37% |
| 1994 | 1.9 Million USD | 18.75% |
| 1993 | 1.6 Million USD | -5.88% |
| 1992 | 1.7 Million USD | 70.0% |
| 1991 | 1 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 1.45 Million USD | -0.86% |
| 2024 Q4 | 1.02 Million USD | -44.88% |
| 2024 Q1 | 1.46 Million USD | -16.8% |
| 2024 Q3 | 1.85 Million USD | 28.1% |
| 2023 Q4 | 1.75 Million USD | 1.33% |
| 2023 Q3 | 1.73 Million USD | -36.3% |
| 2023 Q2 | 2.72 Million USD | 58.02% |
| 2023 Q1 | 1.72 Million USD | 19.65% |
| 2023 FY | 7.73 Million USD | 56.94% |
| 2022 Q4 | 1.44 Million USD | -16.6% |
| 2022 FY | 4.92 Million USD | 43.53% |
| 2022 Q1 | 639.03 Thousand USD | -18.69% |
| 2022 Q2 | 1.11 Million USD | 75.2% |
| 2022 Q3 | 1.72 Million USD | 54.36% |
| 2021 Q2 | 854.44 Thousand USD | -12.38% |
| 2021 Q4 | 785.94 Thousand USD | -3.92% |
| 2021 FY | 3.43 Million USD | 2.11% |
| 2021 Q1 | 975.17 Thousand USD | 49.22% |
| 2021 Q3 | 818.02 Thousand USD | -4.26% |
| 2020 Q3 | 817.01 Thousand USD | -10.99% |
| 2020 Q1 | 974.11 Thousand USD | 14.83% |
| 2020 FY | 3.36 Million USD | 58.43% |
| 2020 Q4 | 653.5 Thousand USD | -20.01% |
| 2020 Q2 | 917.93 Thousand USD | -5.77% |
| 2019 Q1 | 462.5 Thousand USD | -17.23% |
| 2019 Q2 | 355.72 Thousand USD | -23.09% |
| 2019 Q4 | 848.31 Thousand USD | 86.06% |
| 2019 FY | 2.12 Million USD | 43.23% |
| 2019 Q3 | 455.93 Thousand USD | 28.17% |
| 2018 Q4 | 558.8 Thousand USD | 136.63% |
| 2018 FY | 1.48 Million USD | 91.53% |
| 2018 Q1 | 386.74 Thousand USD | 114.69% |
| 2018 Q2 | 300.22 Thousand USD | -22.37% |
| 2018 Q3 | 236.15 Thousand USD | -21.34% |
| 2017 Q3 | 278.12 Thousand USD | 87.41% |
| 2017 FY | 773.72 Thousand USD | -17.87% |
| 2017 Q1 | 167.05 Thousand USD | -47.65% |
| 2017 Q2 | 148.4 Thousand USD | -11.16% |
| 2017 Q4 | 180.14 Thousand USD | -35.23% |
| 2016 FY | 942.02 Thousand USD | 18.01% |
| 2016 Q3 | 273.53 Thousand USD | 26.04% |
| 2016 Q2 | 217.02 Thousand USD | 63.99% |
| 2016 Q1 | 132.33 Thousand USD | -37.19% |
| 2016 Q4 | 319.12 Thousand USD | 16.67% |
| 2015 Q3 | 312.92 Thousand USD | 92.56% |
| 2015 FY | 798.27 Thousand USD | -0.32% |
| 2015 Q2 | 162.51 Thousand USD | 44.92% |
| 2015 Q1 | 112.13 Thousand USD | -23.15% |
| 2015 Q4 | 210.69 Thousand USD | -32.67% |
| 2014 Q1 | 260.23 Thousand USD | -8.96% |
| 2014 Q3 | 189.23 Thousand USD | -7.88% |
| 2014 FY | 800.79 Thousand USD | 22.37% |
| 2014 Q2 | 205.41 Thousand USD | -21.06% |
| 2014 Q4 | 145.91 Thousand USD | -22.89% |
| 2013 Q1 | 129.47 Thousand USD | -56.33% |
| 2013 Q4 | 285.85 Thousand USD | 80.05% |
| 2013 Q2 | 80.33 Thousand USD | -37.95% |
| 2013 Q3 | 158.76 Thousand USD | 97.62% |
| 2013 FY | 654.42 Thousand USD | 17.41% |
| 2012 FY | 557.4 Thousand USD | -25.89% |
| 2012 Q3 | 10.32 Thousand USD | -90.73% |
| 2012 Q2 | 111.32 Thousand USD | -20.08% |
| 2012 Q1 | 139.29 Thousand USD | -19.34% |
| 2012 Q4 | 296.46 Thousand USD | 2771.93% |
| 2011 FY | 752.11 Thousand USD | -42.02% |
| 2011 Q1 | 352.23 Thousand USD | -25.5% |
| 2011 Q2 | 92.79 Thousand USD | -73.66% |
| 2011 Q3 | 134.4 Thousand USD | 44.85% |
| 2011 Q4 | 172.68 Thousand USD | 28.48% |
| 2010 Q4 | 472.81 Thousand USD | 28.96% |
| 2010 Q2 | 238.75 Thousand USD | 9.01% |
| 2010 Q3 | 366.63 Thousand USD | 53.56% |
| 2010 Q1 | 219.02 Thousand USD | -53.63% |
| 2010 FY | 1.29 Million USD | -18.7% |
| 2009 Q1 | 304.14 Thousand USD | 31.59% |
| 2009 FY | 1.59 Million USD | 101.47% |
| 2009 Q2 | 490.28 Thousand USD | 61.2% |
| 2009 Q3 | 328.85 Thousand USD | -32.93% |
| 2009 Q4 | 472.39 Thousand USD | 43.65% |
| 2008 FY | 792 Thousand USD | 66.64% |
| 2008 Q2 | 90.02 Thousand USD | -70.61% |
| 2008 Q1 | 306.29 Thousand USD | 33.53% |
| 2008 Q4 | 231.13 Thousand USD | 40.47% |
| 2008 Q3 | 164.54 Thousand USD | 82.77% |
| 2007 Q3 | 4.25 Million USD | 2654.44% |
| 2007 FY | 475.27 Thousand USD | 11600.47% |
| 2007 Q4 | 229.38 Thousand USD | -94.61% |
| 2007 Q2 | 154.37 Thousand USD | 1456.06% |
| 2007 Q1 | -11.38 Thousand USD | -130.12% |
| 2006 Q2 | 42.07 Thousand USD | 141.28% |
| 2006 Q1 | -101.91 Thousand USD | 69.77% |
| 2006 FY | 4062.00 USD | 100.63% |
| 2006 Q4 | 37.79 Thousand USD | 44.73% |
| 2006 Q3 | 26.11 Thousand USD | -37.93% |
| 2005 Q2 | -175.41 Thousand USD | -90.25% |
| 2005 Q4 | -337.18 Thousand USD | -684.88% |
| 2005 Q3 | -42.96 Thousand USD | 75.51% |
| 2005 Q1 | -92.2 Thousand USD | 64.86% |
| 2005 FY | -647.76 Thousand USD | -8.33% |
| 2004 Q1 | 52.54 Thousand USD | 151.97% |
| 2004 Q4 | -262.36 Thousand USD | -70.94% |
| 2004 Q3 | -153.48 Thousand USD | 34.59% |
| 2004 Q2 | -234.64 Thousand USD | -546.57% |
| 2004 FY | -597.93 Thousand USD | -282.87% |
| 2003 Q1 | 10.7 Thousand USD | 112.86% |
| 2003 Q4 | -101.1 Thousand USD | -132.85% |
| 2003 Q3 | 307.81 Thousand USD | 180.96% |
| 2003 Q2 | 109.56 Thousand USD | 923.45% |
| 2003 FY | 326.97 Thousand USD | 124.24% |
| 2002 FY | -1.34 Million USD | -266.71% |
| 2002 Q2 | -153.41 Thousand USD | 84.74% |
| 2002 Q1 | -1 Million USD | -94.42% |
| 2002 Q3 | -107.13 Thousand USD | 30.16% |
| 2002 Q4 | -83.27 Thousand USD | 22.27% |
| 2001 Q1 | 518.82 Thousand USD | 11.08% |
| 2001 FY | 809.14 Thousand USD | -46.95% |
| 2001 Q3 | 443.55 Thousand USD | 21.94% |
| 2001 Q4 | -516.96 Thousand USD | -216.55% |
| 2001 Q2 | 363.73 Thousand USD | -29.89% |
| 2000 FY | 1.52 Million USD | 27.1% |
| 2000 Q4 | 467.07 Thousand USD | 40.99% |
| 2000 Q3 | 331.28 Thousand USD | 10.43% |
| 2000 Q2 | 300 Thousand USD | -25.0% |
| 2000 Q1 | 400 Thousand USD | 300.0% |
| 1999 FY | 1.2 Million USD | 33.33% |
| 1999 Q1 | 300 Thousand USD | 200.0% |
| 1999 Q2 | 500 Thousand USD | 66.67% |
| 1999 Q3 | 400 Thousand USD | -20.0% |
| 1999 Q4 | 100 Thousand USD | -75.0% |
| 1998 FY | 900 Thousand USD | -59.09% |
| 1998 Q4 | 100 Thousand USD | -50.0% |
| 1998 Q1 | 400 Thousand USD | 33.33% |
| 1998 Q2 | 200 Thousand USD | -50.0% |
| 1998 Q3 | 200 Thousand USD | 0.0% |
| 1997 Q3 | 200 Thousand USD | -71.43% |
| 1997 Q1 | 900 Thousand USD | 12.5% |
| 1997 Q4 | 300 Thousand USD | 50.0% |
| 1997 FY | 2.2 Million USD | -21.43% |
| 1997 Q2 | 700 Thousand USD | -22.22% |
| 1996 FY | 2.8 Million USD | 0.0% |
| 1996 Q2 | 700 Thousand USD | -12.5% |
| 1996 Q1 | 800 Thousand USD | -20.0% |
| 1996 Q4 | 800 Thousand USD | 14.29% |
| 1996 Q3 | 700 Thousand USD | 0.0% |
| 1995 Q4 | 1 Million USD | 42.86% |
| 1995 Q2 | 700 Thousand USD | 75.0% |
| 1995 Q1 | 400 Thousand USD | 0.0% |
| 1995 FY | 2.8 Million USD | 47.37% |
| 1995 Q3 | 700 Thousand USD | 0.0% |
| 1994 Q3 | 500 Thousand USD | 25.0% |
| 1994 Q1 | 400 Thousand USD | 33.33% |
| 1994 Q2 | 400 Thousand USD | 0.0% |
| 1994 FY | 1.9 Million USD | 18.75% |
| 1994 Q4 | 400 Thousand USD | -20.0% |
| 1993 Q1 | 300 Thousand USD | -76.92% |
| 1993 Q4 | 300 Thousand USD | -40.0% |
| 1993 Q3 | 500 Thousand USD | 0.0% |
| 1993 FY | 1.6 Million USD | -5.88% |
| 1993 Q2 | 500 Thousand USD | 66.67% |
| 1992 FY | 1.7 Million USD | 70.0% |
| 1992 Q2 | 1.5 Million USD | -6.25% |
| 1992 Q1 | 1.6 Million USD | 45.45% |
| 1992 Q4 | 1.3 Million USD | -7.14% |
| 1992 Q3 | 1.4 Million USD | -6.67% |
| 1991 Q1 | 1.1 Million USD | 0.0% |
| 1991 Q3 | 1.1 Million USD | 0.0% |
| 1991 Q4 | 1.1 Million USD | 0.0% |
| 1991 FY | 1 Million USD | 0.0% |
| 1991 Q2 | 1.1 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 56.3 Million USD | 89.703% |
| AngioDynamics, Inc. | 154.69 Million USD | 96.252% |
| AtriCure, Inc. | 300.37 Million USD | 98.07% |
| Avinger, Inc. | 2 Million USD | -189.455% |
| Azenta, Inc. | 263.14 Million USD | 97.797% |
| BioLife Solutions, Inc. | 46.75 Million USD | 87.599% |
| The Cooper Companies, Inc. | 2.35 Billion USD | 99.754% |
| Daxor Corporation | 1.1 Million USD | -425.427% |
| Ekso Bionics Holdings, Inc. | 9.07 Million USD | 36.141% |
| Femasys Inc. | 691.9 Thousand USD | -737.949% |
| GlucoTrack, Inc. | -13 Thousand USD | 44698.285% |
| Harvard Bioscience, Inc. | 60.86 Million USD | 90.475% |
| Hologic, Inc. | 2.22 Billion USD | 99.74% |
| ICU Medical, Inc. | 739.87 Million USD | 99.216% |
| Intuitive Surgical, Inc. | 4.72 Billion USD | 99.877% |
| KORU Medical Systems, Inc. | 16.7 Million USD | 65.3% |
| LeMaitre Vascular, Inc. | 127.04 Million USD | 95.437% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 4958.649% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 4958.649% |
| Masimo Corporation | 1 Billion USD | 99.422% |
| Microbot Medical Inc. | -106 Thousand USD | 5569.601% |
| Meihua International Medical Technologies Co., Ltd. | 33.09 Million USD | 82.481% |
| Merit Medical Systems, Inc. | 583.87 Million USD | 99.007% |
| Nephros, Inc. | 8.4 Million USD | 31.02% |
| NovoCure Limited | 381.05 Million USD | 98.479% |
| NEXGEL, Inc. | 619 Thousand USD | -836.636% |
| NEXGEL, Inc. | 619 Thousand USD | -836.636% |
| Singular Genomics Systems, Inc. | -558 Thousand USD | 1139.028% |
| OraSure Technologies, Inc. | 179.42 Million USD | 96.769% |
| Pro-Dex, Inc. | 14.55 Million USD | 60.155% |
| Pulse Biosciences, Inc. | -1.2 Million USD | 580.346% |
| Predictive Oncology Inc. | 1.14 Million USD | -406.225% |
| QuidelOrtho Corporation | 1.49 Billion USD | 99.612% |
| Repligen Corporation | 315.22 Million USD | 98.161% |
| Sanara MedTech Inc. | 57.13 Million USD | 89.853% |
| STAAR Surgical Company | 252.65 Million USD | 97.705% |
| Sharps Technology, Inc. | -891.24 Thousand USD | 750.523% |
| Utah Medical Products, Inc. | 30.03 Million USD | 80.699% |
| DENTSPLY SIRONA Inc. | 2.08 Billion USD | 99.722% |
| Jin Medical International Ltd. | 6.78 Million USD | 14.548% |